Solstice says new RNAi delivery tech will rekindle Big Pharma interest
Solstice Biologics says its new “limitless” RNAi technology will win back Big Pharmas previously put off by delivery difficulties.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs